The CDKN2A/B rs10811661 polymorphism is associated with metabolic syndrome, insulin resistance, and lipid levels in individuals with obesity and impaired fasting glucose

Clinical Biochemistry · Published 2026-01-24 · DOI 10.1016/j.clinbiochem.2026.111089

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.clinbiochem.2026.111089

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles